Gastrointestinal cancer. Malignant neoplasm of ill-defined sites within the digestive system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study The patient's mental and physical readiness and suitability to participate in the study Diagnosis of gastrointestinal cancer based on the information available in the patient's medical records Ability to actively participate in the treatment process (no visual impairment, no hearing problems, adequate speech ability, and literacy in reading and writing)
Exclusion criteria
Exclusion criteria: Presence of severe and active psychiatric disorders such as schizophrenia, uncontrolled bipolar disorder, or acute psychosis. History of psychiatric hospitalization within the past six months or regular use of antipsychotic medications. Presence of moderate to severe cognitive impairments (such as dementia or intellectual disability) that interfere with understanding the content of therapy. History of active seizures or uncontrolled epilepsy (especially in patients assigned to the virtual reality intervention group). Concurrent participation in other psychotherapeutic or psychological interventions during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hope. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Snyder Hope Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Numeric Rating Scale.;Anxiety. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Hospital Anxiety and Depression Scale.;Depression. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Hospital Anxiety and Depression Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences